Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Safety of Synthetic Cannabidiol in Pediatric Childhood Absence Seizures
NCT03355300Phase 2Terminated
- Start
- Feb 2018
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cannabidiol in childhood absence epilepsy (CAE). Started Feb 2018; status: terminated.
02
Drugs
cannabidiol
03
Conditions
childhood absence epilepsy (CAE)
Beyond the preview
Go deeper on NCT03355300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03355300.